NR3A NMDA receptor subunit mRNA expression in schizophrenia, depression and bipolar disorder

Schizophrenia Research

Volumn 71, Issue 2-3, 2004, Pages 361-370

  Mueller, Helena T ^a   Meador Woodruff, James H ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Development; Glutamate receptor; Prefrontal cortex; Psychosis; Temporal cortex

Indexed keywords

GLUTAMATE RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN SUBUNIT;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEASUREMENT; NEOCORTEX; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; TEMPORAL CORTEX;

ADULT; BIPOLAR DISORDER; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PREFRONTAL CORTEX; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE; RNA, MESSENGER; SCHIZOPHRENIA; TEMPORAL LOBE;

EID: 4944261986     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2004.02.016     Document Type: Article

References (31)

1. Akbarian S., Sucher N.J., Bradley D., Tafazzoli A., Trinh D., Hetrick W.P., Potkin S.G., Sandman C.A., Bunney W.E. Jr., Jones E.G. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 16:1996;19-30
2. Bunney W.E., Bunney B.G. Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res. Brain Res. Rev. 31:2000;138-146
3. Burgoyne R.D., Graham M.E., Cambray-Deakin M. Neurotrophic effects of NMDA receptor activation on developing cerebellar granule cells. J. Neurocytol. 22:1993;689-695
4. Chan S.F., Sucher N.J. An NMDA receptor signaling complex with protein phosphatase 2A. J. Neurosci. 21:2001;7985-7992
5. Chatterton J.E., Awobuluyi M., Premkumar L.S., Takahashi H., Talantova M., Shin Y., Cui J., Tu S., Sevarino K.A., Nakanishi N., Tong G., Lipton S.A., Zhang D. Excitatory glycine receptors containing the NR3 family of NMDA receptor subunits. Nature. 415:2002;793-798
6. Ciabarra A.M., Sullivan J.M., Gahn L.G., Pecht G., Heinemann S., Sevarino K.A. Cloning and characterization of chi-1: a developmentally regulated member of a novel class of the ionotropic glutamate receptor family. J. Neurosci. 15:1995;6498-6508
7. Curtis V.A., Dixon T.A., Morris R.G., Bullmore E.T., Brammer M.J., Williams S.C., Sharma T., Murray R.M., McGuire P.K. Differential frontal activation in schizophrenia and bipolar illness during verbal fluency. J. Affect. Disord. 66:2001;111-121
8. Das S., Sasaki Y.F., Rothe T., Premkumar L.S., Takasu M., Crandall J.E., Dikkes P., Conner D.A., Rayudu P.V., Cheung W., Chen H.S., Lipton S.A., Nakanishi N. Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A. Nature. 393:1998;377-381
9. Dean B., Pavey G., McLeod M., Opeskin K., Keks N., Copolov D. A change in the density of [(3)H]flumazenil, but not [(3)H]muscimol binding, in Brodmann's area 9 from subjects with bipolar disorder. J. Affect. Disord. 66:2001;147-158
10. Dracheva S., Marras S.A., Elhakem S.L., Kramer F.R., Davis K.L., Haroutunian V. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. Am. J. Psychiatry. 158:2001;1400-1410
11. Gao X.M., Sakai K., Roberts R.C., Conley R.R., Dean B., Tamminga C.A. Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry. 157:2000;1141-1149
12. Garey L.J., Ong W.Y., Patel T.S., Kanani M., Davis A., Mortimer A.M., Barnes T.R., Hirsch S.R. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J. Neurol. Neurosurg. Psychiatry. 65:1998;446-453
13. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry. 57:2000;65-73
14. Goff D.C., Coyle J.T. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. Am. J. Psychiatry. 158:2001;1367-1377
15. Greengard P., Allen P.B., Nairn A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron. 23:1999;435-447
16. Hollmann M., Heinemann S. Cloned glutamate receptors. Annu. Rev. Neurosci. 17:1994;31-108
17. Ishimaru M., Kurumaji A., Toru M. NMDA-associated glycine binding site increases in schizophrenic brains. Biol. Psychiatry. 32:1992;379-381
18. Law A.J., Deakin J.F. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. NeuroReport. 12:2001;2971-2974
19. Lidow M.S. Calcium signaling dysfunction in schizophrenia: a unifying approach. Brain Res. Brain Res. Rev. 43:2003;70-84
20. Lipska B.K., Weinberger D.R. A neurodevelopmental model of schizophrenia: neonatal disconnection of the hippocampus. Neurotox. Res. 4:2002;469-475
21. Marenco S., Weinberger D.R. The neurodevelopmental hypothesis of schizophrenia: following a trail of evidence from cradle to grave. Dev. Psychopathol. 12:2000;501-527
22. Meador-Woodruff J.H., Healy D.J. Glutamate receptor expression in schizophrenic brain. Brain Res. Brain Res. Rev. 31:2000;288-294
23. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J. Neurosci. 17:1997;2921-2927
24. Mueller H.T., Meador-Woodruff J.H. Expression of the NR3A subunit of the NMDA receptor in human fetal brain. Ann. N.Y. Acad. Sci. 1003:2003;448-456
25. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J. Psychiatr. Res. 33:1999;523-533
26. Scarr E., Pavey G., Sundram S., MacKinnon A., Dean B. Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord. 5:2003;257-264
27. Sokolov B.P. Expression of NMDAR1, GluR1, GluR7, and KA1 glutamate receptor mRNAs is decreased in frontal cortex of "neuroleptic-free" schizophrenics: evidence on reversible up-regulation by typical neuroleptics. J. Neurochem. 71:1998;2454-2464
28. Sucher N.J., Akbarian S., Chi C.L., Leclerc C.L., Awobuluyi M., Deitcher D.L., Wu M.K., Yuan J.P., Jones E.G., Lipton S.A. Developmental and regional expression pattern of a novel NMDA receptor-like subunit (NMDAR-L) in the rodent brain. J. Neurosci. 15:1995;6509-6520
29. Torrey E.F., Webster M., Knable M., Johnston N., Yolken R.H. The Stanley foundation brain collection and neuropathology consortium. Schizophr. Res. 44:2000;151-155
30. Vawter M.P., Freed W.J., Kleinman J.E. Neuropathology of bipolar disorder. Biol. Psychiatry. 48:2000;486-504
31. Wood G.K., Lipska B.K., Weinberger D.R. Behavioral changes in rats with early ventral hippocampal damage vary with age at damage. Brain Res. Dev. Brain Res. 101:1997;17-25